ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.

Jesus D Anampa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.